Unveiling the Potential of Novel Life Sciences Platforms in Stem Cells, Microbiome, Computational Genomics, and Advanced Diagnostics

Share this:
Published: 12 Oct 2018

The Life Science, Health & Wellness TOE depicts the current landscape and the new life sciences trends across twelve groundbreaking drug discovery and genetic platforms. Each and every platform is accurately profiled covering the most cutting-edge technologies energizing the pharmaceutical landscape, such as stem cells, gene therapy, personalized genomics, computational biology, and non-invasive diagnostics, among others. The TOE also provides information on clinical trials for stem cells in the US. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Stemgene, human embryonic stem cells, induced pluripotent stem cells, DNA testing, computational genomics, microbiome, hearing aid, cytokine release syndrome

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..